Merocyanine 540 (MC 540) is a photoactive dye used t o purge bone marrow of tumor cells in autologous bone marrow transplantation. The effects of MC 540 on the lymphoid components in the marrow are unknown. This study evaluates the treatment of lymphocytes by MC 540 (15 pg/mL) and light (70 W/mz) on: (1) phytohemagglutinin and Con A-induced proliferation; (2) allogeneic mixed lymphocyte cultures (MLC); (3) the regulation of Ig synthesis by T cells; and (4) the ability of B cells to produce polyclonal Igs as measured by an enzyme-linked immunosorbent assay-plaque assay. The results show that MC 540 and light treatment reduced Con A-stimulated T-cell proliferation greater than 50% after 30 minutes and greater than 80% after 60 minutes of MC 540-sensitized photoirradiation. Ninety minutes of MC 540 and light exposure (designated treatment) inhibited MLC YE-SENSITIZED photoirradiation is a relatively re-D cent addition to the arsenal of techniques used for the elimination of tumor cells from autologous bone marrow (BM) grafts.' One photosensitizer, merocyanine 540 (MC 540), has been characterized extensively in preclinical and is now being used in a phase I clinical trial for extracorporeal purging of autologous marrow grafts in patients with acute lymphocytic or nonlymphocytic leukemia, Hodgkin's or non-Hodgkin's lymphoma, or stage IV neuroblastoma.'o~"
Merocyanine 540 (MC 540) is a photoactive dye used t o purge bone marrow of tumor cells in autologous bone marrow transplantation. The effects of MC 540 on the lymphoid components in the marrow are unknown. This study evaluates the treatment of lymphocytes by MC 540 (15 pg/mL) and light (70 W/mz) on: (1) phytohemagglutinin and Con A-induced proliferation; (2) allogeneic mixed lymphocyte cultures (MLC); (3) the regulation of Ig synthesis by T cells; and (4) the ability of B cells to produce polyclonal Igs as measured by an enzyme-linked immunosorbent assay-plaque assay. The results show that MC 540 and light treatment reduced Con A-stimulated T-cell proliferation greater than 50% after 30 minutes and greater than 80% after 60 minutes of MC 540-sensitized photoirradiation. Ninety minutes of MC 540 and light exposure (designated treatment) inhibited MLC YE-SENSITIZED photoirradiation is a relatively re-D cent addition to the arsenal of techniques used for the elimination of tumor cells from autologous bone marrow (BM) grafts.' One photosensitizer, merocyanine 540 (MC 540), has been characterized extensively in preclinical and is now being used in a phase I clinical trial for extracorporeal purging of autologous marrow grafts in patients with acute lymphocytic or nonlymphocytic leukemia, Hodgkin's or non-Hodgkin's lymphoma, or stage IV neuroblastoma.'o~"
The preclinical evaluation of MC 540 has shown that MC 540 has a low acute systemic toxicity" and low mutagenic potential." It preferentially photosensitizes normal erythroid progenitor cells, leukemiabymphoma cell^,'^*^^-^ and neuroblastoma cell^.'^^ By contrast, pluripotent hematopoietic progenitor cells as measured by day 12 colony-forming unit-spleen (CFU-S) or CFU-granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM) are quite resistant to MC 540-sensitized ph~toirradiation~.'~ and substantial reductions of tumor cell concentrations can be achieved without causing excessive damage to the graft's capacity to rescue lethally irradiated h o s t~. '~~~~~~'~ In all of the reported animal experiments, survival was the end-point and the exact kinetics of hematopoietic and lymphopoietic reconstitution were not determined. The kinetics of the hematopoietic and lymphopoietic recovery may be influenced by T cells and accessory cells (ie, cells other than the pluripotent hematopoietic stem cell) and it is conceivable that the damage done to T cells and accessory cells by a given purging procedure may affect clinical transplantation. This report addresses the effects of MC 540-sensitized photoirradiation on the functions of T and B cells.
Specifically, we ask whether treatment with MC 540-sensitized photoirradiation: (1) modulates T-cell proliferative responses to mitogens; (2) alters the ability of T cells to respond to alloantigens; (3) modulates T-cell helper activity; and (4) affects the ability of B cells to produce polyclonal Ig. In this study, we show that treatment with MC 540 and white light is a potent inhibitor of T-and B-lymphocyte functions at doses of dye and light comparable with or lower than those used in clinical trials.
MATERIALS AND METHODS

Viability after dye-mediatedphotoiradiation (DMP).
Viability of the lymphocytes used for these assays was checked before culture and at 2, 6, and 24 hours after MC 540 DMP using trypan blue exclusion.
Peripheral blood mononuclear cells (PBMC) were purified by Ficoll-hypaque density gradient centrifugation (F/H) of whole heparinized blood. T (E+) and non-T (E-) subpopulations were separated by rosetting with 2-aminoethylisothiuronium bromide hydrobromide-modified sheep red blood cells (RBC) as described." The T-cell populations were greater than 95% E+ cells and the non-T-cell populations contained less than 5% E+ cells by rosetting.
Unless otherwise mentioned, the initial lymphocytes placed into culture were viable based on trypan blue exclusion after treatment. RPMI 1640 supplemented with penicillinstreptomycin, 4 mmol/L glutamine, and 10% fetal bovine serum (FBS; Hyclone, Logan, UT) was used for culture except for the mixed lymphocyte cultures. Human AI3 serum (10%) was used in the mixed lymphocyte cultures. 'H-thymidine incorporation after Lymphocyte separation.
Immune assays.
For personal use only. Costar (3530) petri dishes (Cambridge, MA)." The lymphocytes were cultured on the petri dishes overnight at 37°C in a 5% CO, incubator. The next morning, the lymphocytes were discarded and the dishes washed with PBST and incubated with 2 mL of pretitrated alkaline phosphatase-conjugated goat antihuman IgG or IgM (TAGO, Burlingame, CA) in 10 mmol/L phosphate buffer for 4 hours at 37°C. After incubation with the developing antibody, the dishes were washed with PBST and coated with 2 mL of 5-bromo-4-chloro-3-indolylphosphate in 2-amino-2-methyl-1-propanol (AMP) buffer in a 0.03% solution of gelling agarose at a final concentration of 1 mg/mL. Plaque forming cells (PFC) were identified as blue spots in the agarose and were counted with an image analysis system using a dissecting microscope (WILD M3Z, Leitz, Overland Park, KS), an MTI 65 video camera, and a 286 IBM compatible computer equipped with the BQ Meg IV System (R & M Biometrics, Nashville, TN). A representative area was counted and expressed as numbers of PFC per lo6 B cells cultured as indicated in the results. All PFC data were corrected for unstimulated T-and B-cell cultures in the PWM-stimulated assays or for unstimulated B cells in the EBVstimulated assays.
The MC 540-sensitized photoirradiation of cells was performed as described previo~sly.'~ Briefly, cells were suspended at a concentration of 1 to MC 540-sensitizedphotoiradiation.
received either no treatment or were exposed to MC 540 in the dark or to light only served as controls.
RESULTS
Eability after DMP.
Incubation of lymphocytes with MC 540 alone in the dark or light alone for 90 minutes did not affect viability as measured by trypan blue exclusion.
Viability was greater than a mean of 90% after 6 hours of culture and greater than a mean of 75% after 24 hours of culture. After 30 minutes of MC 540 DMP, viability after 6 hours of culture was a mean of 97% and after 24 hours of culture was a mean of 92%.
In an earlier report,6 there were 15% less viable cells in long-term cultures of normal human BM treated for 30 minutes with DMP than in untreated long-term cultures. In the same report, burst-forming unit-erythroid (BFU-E), CFU-erythroid (CFU-E), and CFU-granulocyte-macrophage (CFU-GM) were assayed immediately after the dye-sensitized photoirradiation treatment of the human BM cell suspensions (data not shown). After 30 minutes of DMP, BFU-E, CFU-E, and CFU-GM were reduced from means of 6,250 to 2,300, 10,700 to 725, and 8,700 to 8,500 colonies, respectively.6 These data, obtained under the same experimental circumstances, show the relative sensitivities of each of the hematopoietic progenitor cells to DMP.6
Suppression of mitogen-stimulated lymphocyte proliferation. Mitogen-induced proliferative responses of PBMC were progressively inhibited by increasing doses of light at a constant dose of MC 540 (15 kg/mL). Figure 1A shows the data from one of six representative experiments where treatment with MC 540 and increasing doses of white light decreased the ability of PBMC to incorporate 3H-thymidine when stimulated with PHA. Figure 1A shows that PHAstimulated 3H-thymidine incorporation was inhibited by greater than 80% and 98% after 30 and 60 minutes of treatment, respectively.
In the six experiments performed using PHA, the mean PHA-stimulated proliferation for control (untreated) PBMC was 29,362 cpm with a range from 3,366 to 68,129 cpm. MC 540 treatment alone did not alter proliferation. PHAstimulated proliferation was inhibited by a mean of 70% f 8% ( f 1 SD), 98% 2 2%, and 98% f 3% after 30,60, and 90 minutes of treatment, respectively. The range of inhibition of the PHA-stimulated control ranged from 61% t o 79% after 30 minutes, 96% to 100% after 60 minutes, and 92% to 100% after 90 minutes.
Similarly, MC 540 and light treatments progressively inhibited Con A-induced proliferation of control PBMC with increasing doses of light exposure. Figure 1B shows representative data from one of four experiments. Figure 1 shows that Con A-induced lymphocyte proliferation was inhibited by greater than 90% and 99% after 30 and 60 minutes of treatment, respectively.
The mean Con A-stimulated proliferation for control (untreated) PBMC for four experiments was 22,845 cpm f 21,462 (f 1 SD) with a range from 2,148 to 55,375 cpm. Con A-stimulated proliferation was inhibited by a mean of 75% f 18% (fl SD), 96.5% f 3%, and 94% after 30,60, and 90 minutes of treatment with MC 540 and light, respectively. The inhibition of the Con A-stimulated control ranged from 50% to 94% after 30 minutes, 92% to 100% after 60 minutes, and 92% to 97% after 90 minutes. MC 540 treatment alone did not alter Con A-stimulated proliferation. In summary, after only 30 minutes of MC 540 and light, PHA and Con A-stimulated proliferation was inhibited a mean of 70% and 75%, respectively. By 90 minutes of treatment, PHA and Con A-stimulated proliferation was inhibited greater than 90%.
Effects of MC 540 and light on PWXf-induced Zg synthesis. Cocultures of T and B cells were performed to determine the effects of MC 540 and light on T-cell helper function and on B-cell function in the T-cell-dependent PWMstimulated Ig synthesis system. Figure 2A and B shows two representative experiments of five that demonstrate the effects of the MC 540 and light treatment on PWMstimulated IgG and IgM synthesis as measured by an ELISA-plaque assay. The results are reported as the total number of IgG and IgM PFC per lo6 non-T cells cultured after background corrections for unstimulated PFC. Control cultures containing PWM-stimulated T and B cells produced 6,800 PFC and 14,700 PFC/106 B cells cultured (Fig 2A and B, 
respectively). T cells (T,) or non-T cells (B,) treated with only MC 540 or MC 540 and light for 30
minutes (TM3J did not inhibit the number of PFC detected after 6 days of culture. Sixty minutes of MC 540 and light treatment had almost no effect on T-cell helper activity in the normal subject in Fig 2A but 
DISCUSSION
This investigation shows that treatment with MC 540 and light has major effects on T-and B-lymphocyte functions. MC 540 DMP inhibits T-cell proliferation, the generation of T-cell helper activity, B-cell differentiation, and MLC. Some dye-sensitized photoirradiation effects on T and B cells may be related to differential loss of specific lymphoid subpopulations as well as a reduction in cell numbers. However, more interesting are the effects of MC 540 DMP on the remaining viable cells. In the latter circumstance, there are several mechanisms that may explain impaired Tand B-cell functions. One explanation is that there may be delayed death of the treated cells, ie, T and B cells may be irreversibly damaged by the treatment yet continue to exclude trypan blue and then go on to die 2 or 3 days later. A more interesting alternative explanation is that the remaining T and B cells were inhibited in their ability to function due to DMP.
The inhibition of T-cell helper functions seen in the mitogen-induced T-cell proliferation and Ig biosynthesis suggest that MC 540-sensitized photoirradiation may affect a variety of T-cell functions. Some of these impaired T-cell functions may alter the rate of hematopoietic engraftment.
In all of the functions tested, T-cell helper function in PWM-stimulated Ig synthesis was more resistant to MC 540 DMP than mitogen-or alloantigen-induced proliferative responses. We hypothesize that pathways for cell proliferation may be more sensitive to MC 540 and light treatment than pathways responsible for lymphokine synthesis. Additional studies are being performed to further dissect the effects of MC 540 DMP on the molecular mechanisms involved in T-cell activation for helper function and alloreactivity.
The dose titrations used in this study were performed at doses equal to or less than those used in the phase I clinical trial for extracorporeal purging of autologous marrow grafts from patients with acute leukemias, lymphomas, or stage IV Therefore, it is possible that the prolonged neutropenia or delayed engraftment in some patients receiving extracorporeally purged autologous marrow grafts was due to either reduced numbers of T cells in The inhibition of mitogen-induced and: alloantigeninduced T-cell proliferation is remarkable. PHA-induced or Con A-induced proliferative responses were consistently inhibited greater than 70% after 30 minutes of treatment. The ability of B cells to secrete Ig in PWM-or EBVstimulated Ig secretion was inhibited. MC 540-sensitized photoirradiation of PBMC completely blocked allogeneic MLC remonses in all six combinations studied. These studies shbw that MC 540 at a dose of 15 Fg/mL and white 0 30
90
light (70 Wim') exposure for 90 minutes could inhibit MLC greater than 90%. We emphasize that these studies were performed on viable lymphocytes after the MC 540 DMP. It is not ' Iear whether these MC 540 and light doses could be used in clinical situations to inhibit reactions such as graft-versus-host disease (GVHD). These situations include where: (1) a related donor and recipient are mismatched for antigens; Or (2) an donor and the recipient are phenotypicalb mismatched for one antigen. These are situations in which T-cell depletion or For personal use only. on October 22, 2017. by guest www.bloodjournal.org From modulation may markedly reduce the incidence and the overall severity of GVHD. Mixed lymphocyte culture studies between family members with known HLA differences may provide information on optimal doses of dye and light needed to decrease the incidence and severity of acute GVHD in partially mismatched transplants. If such studies are successful, MC 540 DMP of the allogeneic marrow inocula would provide a tool for modulating GVHD and expand the use of marrow grafting to patients with unrelated or partially mismatched marrow grafts as an alternative to other means of modulating the marrow inoculum to prevent acute GVHD.
Finally, the direct effect of MC 540 DMP on B cells may be clinically important for several reasons. MC 540 DMP may directly inhibit B cells from proliferating and differentiating into producing Ig cells by eliminating them before activation, or inhibit the activation of B cells. In the EBV system, it may inhibit EBV from infecting normal B cells by altering the EBV receptors on the cell membrane surface. Experiments are being performed to test these hypotheses. Studies are in progress to elucidate the specific mechanisms responsible for the modulation of T-and B-cell functions in PBMC as well as bone marrow mononuclear cells.
